Sally C. Medley

Array ( [id] => 3808060 [patent_doc_number] => 05831023 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Recombinant animal interferon polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/444454 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 13984 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 260 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/831/05831023.pdf [firstpage_image] =>[orig_patent_app_number] => 444454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3872027 [patent_doc_number] => 05824509 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Recombinant lymphotoxin cDNA and variants' [patent_app_type] => 1 [patent_app_number] => 8/444653 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15918 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824509.pdf [firstpage_image] =>[orig_patent_app_number] => 444653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3728712 [patent_doc_number] => 05652210 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Soluble splice variant of the Fas (APO-1) antigen, Fas.DELTA.TM' [patent_app_type] => 1 [patent_app_number] => 8/444231 [patent_app_country] => US [patent_app_date] => 1995-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 6874 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652210.pdf [firstpage_image] =>[orig_patent_app_number] => 444231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3854895 [patent_doc_number] => 05705363 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Recombinant production of human interferon .tau. polypeptides and nucleic acids' [patent_app_type] => 1 [patent_app_number] => 8/438753 [patent_app_country] => US [patent_app_date] => 1995-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 28 [patent_no_of_words] => 31124 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705363.pdf [firstpage_image] =>[orig_patent_app_number] => 438753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3663048 [patent_doc_number] => 05599559 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Calcium channel blocking polypeptide from agelenopsis aperta and therapeutic methods employing it' [patent_app_type] => 1 [patent_app_number] => 8/379550 [patent_app_country] => US [patent_app_date] => 1995-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2894 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599559.pdf [firstpage_image] =>[orig_patent_app_number] => 379550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3616135 [patent_doc_number] => 05614185 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Compositions containing reduced, microbially produced interleukin-2 (IL-2)' [patent_app_type] => 1 [patent_app_number] => 8/428895 [patent_app_country] => US [patent_app_date] => 1995-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5352 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614185.pdf [firstpage_image] =>[orig_patent_app_number] => 428895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4109183 [patent_doc_number] => 06022949 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Fungal aureobasidin sensitivity gene products' [patent_app_type] => 1 [patent_app_number] => 8/423752 [patent_app_country] => US [patent_app_date] => 1995-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 22652 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022949.pdf [firstpage_image] =>[orig_patent_app_number] => 423752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695989 [patent_doc_number] => 05677149 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Interleukin-3 (IL-3) mutant polypeptides and their recombinant production' [patent_app_type] => 1 [patent_app_number] => 8/411796 [patent_app_country] => US [patent_app_date] => 1995-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 100569 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677149.pdf [firstpage_image] =>[orig_patent_app_number] => 411796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690332 [patent_doc_number] => 05604116 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-18 [patent_title] => 'Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods' [patent_app_type] => 1 [patent_app_number] => 8/411795 [patent_app_country] => US [patent_app_date] => 1995-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 92054 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/604/05604116.pdf [firstpage_image] =>[orig_patent_app_number] => 411795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3694973 [patent_doc_number] => 05595882 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Angiotensin II type-1 receptor proteins and screening assays using such proteins or transformants expressing them' [patent_app_type] => 1 [patent_app_number] => 8/417122 [patent_app_country] => US [patent_app_date] => 1995-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 9183 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/595/05595882.pdf [firstpage_image] =>[orig_patent_app_number] => 417122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3581130 [patent_doc_number] => 05580788 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-03 [patent_title] => 'Use of immunoglogulin-binding artificial proteins as molecular weight markers' [patent_app_type] => 1 [patent_app_number] => 8/406809 [patent_app_country] => US [patent_app_date] => 1995-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 4660 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/580/05580788.pdf [firstpage_image] =>[orig_patent_app_number] => 406809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3549178 [patent_doc_number] => 05547855 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-20 [patent_title] => 'Kainate-binding human CNS glutamate receptors EAA3C and EAA3D, DNA encoding them, and expression of the DNA in transformed cells' [patent_app_type] => 1 [patent_app_number] => 8/405392 [patent_app_country] => US [patent_app_date] => 1995-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9280 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/547/05547855.pdf [firstpage_image] =>[orig_patent_app_number] => 405392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3645126 [patent_doc_number] => 05637470 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Screening array using cells expressing recombinant .alpha. and .beta. subunits of the mammalian large-conductance (maxi-K) potassium channel' [patent_app_type] => 1 [patent_app_number] => 8/389668 [patent_app_country] => US [patent_app_date] => 1995-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14181 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637470.pdf [firstpage_image] =>[orig_patent_app_number] => 389668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3694264 [patent_doc_number] => 05618720 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'Cells expressing calcium channel .alpha.2 subunit-encoding DNA, optionally with a reporter gene for screening assays' [patent_app_type] => 1 [patent_app_number] => 8/404354 [patent_app_country] => US [patent_app_date] => 1995-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 10621 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618720.pdf [firstpage_image] =>[orig_patent_app_number] => 404354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3616121 [patent_doc_number] => 05614184 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Recombinant human erythropoietin mutants and therapeutic methods employing them' [patent_app_type] => 1 [patent_app_number] => 8/383743 [patent_app_country] => US [patent_app_date] => 1995-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11290 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614184.pdf [firstpage_image] =>[orig_patent_app_number] => 383743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730758 [patent_doc_number] => 05693607 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Uses of TGF-.beta. receptor fragment as a therapeutic agent' [patent_app_type] => 1 [patent_app_number] => 8/361873 [patent_app_country] => US [patent_app_date] => 1994-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 11626 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693607.pdf [firstpage_image] =>[orig_patent_app_number] => 361873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726010 [patent_doc_number] => 05702914 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-30 [patent_title] => 'Use of reporter genes for retinoid receptor screening assays having novel retinoid-associated response elements' [patent_app_type] => 1 [patent_app_number] => 8/360939 [patent_app_country] => US [patent_app_date] => 1994-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10200 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 307 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/702/05702914.pdf [firstpage_image] =>[orig_patent_app_number] => 360939 [rel_patent_id] =>[rel_patent_doc_number] =>)